v3.26.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
Assets    
Cash and due from banks $ 153,492 $ 107,956
Interest-earning deposits 311,756 552,276
Cash and cash equivalents 465,248 [1] 660,232
Securities available for sale (“AFS”), at fair value 2,006,963 859,834
Other investments 116,575 63,247
Loans held for sale 19,388 13,620
Other assets held for sale 411,348 0
Loans 10,848,164 6,836,345
Allowance for credit losses - loans (“ACL-Loans”) (133,584) (68,806)
Loans, net 10,714,580 6,767,539
Premises and equipment, net 189,197 120,462
Bank owned life insurance (“BOLI”) 296,095 192,498
Goodwill and other intangibles, net 961,687 382,400
Accrued interest receivable and other assets 233,538 125,275
Total assets 15,414,619 9,185,107
Liabilities:    
Noninterest-bearing demand deposits 2,717,610 1,828,928
Interest-bearing deposits 9,805,726 5,901,843
Total deposits 12,523,336 7,730,771
Long-term borrowings 92,750 134,860
Other liabilities held for sale 388,060 0
Accrued interest payable and other liabilities 138,999 61,814
Total liabilities 13,143,145 7,927,445
Stockholders’ Equity:    
Common stock 211 148
Additional paid-in capital 1,552,947 583,257
Retained earnings 755,311 697,799
Accumulated other comprehensive income (loss) (36,995) (23,542)
Total stockholders’ equity 2,271,474 1,257,662
Total liabilities and stockholders’ equity $ 15,414,619 $ 9,185,107
Preferred shares authorized (no par value) (in shares) 10,000,000 10,000,000
Preferred shares issued (in shares) 0 0
Preferred shares outstanding (in shares) 0 0
Common shares authorized (par value $0.01 per share) (in shares) 60,000,000 30,000,000
Common shares outstanding (in shares) 21,060,762 14,811,445
Common shares issued (in shares) 21,228,645 14,930,213
[1] Cash and cash equivalents included $10 million and $0.3 million of restricted cash at June 30, 2026 and June 30, 2025, respectively.